ReviewDrug safety2003
Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.
Edwin J Wagena et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled ittrialcites it